Quantification of Tumor Tissue Populations by Multispectral Analysis

Magnetic Resonance in Medicine

Volumn 51, Issue 3, 2004, Pages 542-551

  Carano, Richard A D ^a   Ross, Adrienne L ^a   Ross, Jed ^a   Williams, Simon P ^a   Koeppen, Hartmut ^a   Schwall, Ralph H ^a   Van Bruggen, Nicholas ^a  

^a GENENTECH INC   (United States)

Author keywords

Apo2L TRAIL; Diffusion; K means clustering; Multispectral analysis; Tumor

Indexed keywords

CELL DEATH; DIFFUSION; K-MEANS CLUSTERING; SURFACE DIFFUSION;

APO2L/TRAIL; APPARENT DIFFUSION COEFFICIENT; MULTI-SPECTRAL ANALYSIS; MULTIPLE PARAMETERS; SUBCUTANEOUS ADIPOSE TISSUES; TEMPORAL EVOLUTION; THERAPEUTIC INTERVENTION; TUMOR HETEROGENEITY;

TUMORS;

IRINOTECAN; PROTON; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL MODEL; ANIMAL TISSUE; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CANCER THERAPY; CLASSIFICATION; COLORECTAL TUMOR; CONTROLLED STUDY; DENSITY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DRUG RESPONSE; FEMALE; HUMAN; HUMAN CELL; K MEANS CLUSTERING; MATHEMATICAL ANALYSIS; MOUSE; MULTISPECTRAL ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON DENSITY; QUANTITATIVE ANALYSIS; RELAXATION TIME; SPECTROSCOPY; SUBCUTANEOUS FAT; T2 RELAXATION TIME; TUMOR; TUMOR NECROSIS; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 1542346850     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.10731     Document Type: Article

References (39)

1. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986;161:401-407.
2. Maeda M, Kawamura Y, Tamagawa Y, Matsuda T, Itoh S, Kimura H, Iwasaki T, Hayashi N, Yamamoto K, Ishii Y. Intravoxel incoherent motion (IVIM) MRI in intracranial, extraaxial tumors and cysts. J Comput Assist Tomogr 1992;16:514-518.
3. Helmer KG, Dardzinski BJ, Sotak CH. The application of porous-media theory to the investigation of time-dependent diffusion in in vivo systems. NMR Biomed 1995;8:297-306.
4. Brunberg JA, Chenevert TL, McKeever PE, Ross DA, Junck LR, Muraszko KM, Dauser R, Pipe JG, Betley AT. In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. AJNR Am J Neuroradiol 1995;16:361-371.
5. Maier CF, Paran Y, Bendel P, Rutt BK, Degani H. Quantitative diffusion imaging in implanted human breast tumors. Magn Reson Med 1997;37:576-581.
6. Krabbe K, Gideon P, Wagn P, Hansen U, Thomsen C, Madsen F. MR diffusion imaging of human intracranial tumours. Neuroradiology 1997;39:483-489.
7. Helmer KG, Han S, Sotak CH. On the correlation between the water diffusion coefficient and oxygen tension in RIF-1 tumors. NMR Biomed 1998;11:120-130.
8. Chenevert TL, McKeever PE, Ross BD. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 1997;3:1457-1466.
9. Poptani H, Puumalainen AM, Grohn OH, Loimas S, Kainulainen R, Yla-Herttuala S, Kauppinen RA. Monitoring thymidine kinase and ganciclovir-induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging. Cancer Gene Ther 1998;5:101-109.
10. Galons JP, Altbach MI, Paine-Murrieta GD, Taylor CW, Gillies RJ. Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia 1999;1:113-117.
11. Chinnaiyan AM, Prasad U, Shankar S, Hamstra DA, Shanaiah M, Chenevert TL, Ross BD, Rehemtulla A. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci USA 2000;97:1754-1759.
12. Chenevert TL, Stegman LD, Taylor JM, Robertson PL, Greenberg HS, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000;92:2029-2036.
13. Els T, Eis M, Hoehn-Berlage M, Hossmann KA. Diffusion-weighted MR imaging of experimental brain tumors in rats. MAGMA 1995;3:13-20.
14. Duda RO, Hart PE. Pattern classification and scene analysis. New York: John Wiley & Sons; 1973.
15. Vannier MW, Butterfield RL, Rickman DL, Jordan DM, Murphy WA, Biondetti PR. Multispectral magnetic resonance image analysis. Crit Rev Biomed Eng 1987;15:117-144.
16. Taxt T, Lundervold A, Fuglaas B, Lien H, Abeler V. Multispectral analysis of uterine corpus tumors in magnetic resonance imaging. Magn Reson Med 1992;23:55-76.
17. Vaidyanathan M, Clarke LP, Velthuizen RP, Phuphanich S, Bensaid AM, Hall LO, Bezdek JC, Greenberg H, Trotti A, Silbiger M. Comparison of supervised MRI segmentation methods for tumor volume determination during therapy. Magn Reson Imaging 1995;13:719-728.
18. Gordon J, Mohamed F, Vinitski S, Knobler RL, Curtis M, Faro S, Khalili K. Utililization of experimental animal model for correlative multispectral MRI and pathological analysis of brain tumors. Magn Reson Imaging 1999;17:1495-1502.
19. McClain KJ, Zhu Y, Hazle JD. Selection of MR images for automated segmentation. J Magn Reson Imaging 1995;5:485-492.
20. Tou T, Gonzalez RC. Pattern recognition principles. Reading, MA: Addison-Wesley; 1974.
21. Carano RA, Takano K, Helmer KG, Tatlisumak T, Irie K, Petruccelli JD, Fisher M, Sotak CH. Determination of focal ischemic lesion volume in the rat brain using multispectral analysis. J Magn Reson Imaging 1998;8:1266-1278.
22. Carano RA, Li F, Irie K, Helmer KG, Silva MD, Fisher M, Sotak CH. Multispectral analysis of the temporal evolution of cerebral ischemia in the rat brain. J Magn Reson Imaging 2000;12:842-858.
23. Bezdek JC, Hall LO, Clarke LP. Review of MR image segmentation techniques using pattern recognition. Med Phys 1993;20:1033-1048.
24. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995;3:673-682.
25. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996;271:12687-12690.
26. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281:1305-1308.
27. Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999;11:255-260.
28. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 1999;104:155-162.
29. Kelley SK, Harris LA, Xie D, Deforge L, Totpal K, Bussiere J, Fox JA. Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety. J Pharmacol Exp Ther 2001;299:31-38.
30. Wall ME, Wani MC, Cook CE. Plant anti-tumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J Am Chem Soc 1966;88:3888-3890.
31. Hsiang YH, Liu LF. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res 1988;48:1722-1726.
32. Houghton PJ, Cheshire PJ, Hallman JC, Bissery MC, Mathieu-Boue A, Houghton JA. Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino)-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase I inhibitor 9-dimethylaminomethyl-10-hydroxycamptothecin. Cancer Res 1993;53:2823-2829.
33. Gliniak B, Le T. Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11. Cancer Res 1999;59:6153-6158.
34. Brinkrnann BH, Manduca A, Robb RA. Optimized homomorphic unsharp masking for MR grayscale inhomogeneity correction. IEEE Trans Med Imaging 1998;17:161-171.
35. Jain AK, Dubes RC. Algorithms for clustering data. Englewood Cliffs, NJ: Prentice Hall; 1988.
36. Brindle KM, Brown FF, Campbell ID, Grathwohl C, Kuchel PW. Application of spin-echo nuclear magnetic resonance to whole-cell systems. Membrane transport. Biochem J 1979;180:37-44.
37. Thulborn KR, Waterton JC, Matthews PM, Radda GK. Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field. Biochim Biophys Acta 1982;714:265-270.
38. Bass J, Sostman HD, Boyko O, Koepke JA. Effects of cell membrane disruption on the relaxation rates of blood and clot with various methemoglobin concentrations. Invest Radiol 1990;25:1232-1237.
39. Stark DD, Bradley WG. Musculoskeletal tumors. In: Cora E, editor. Magnetic resonance imaging. St. Louis: Mosby Yearbook, Inc.; 1999. p 369.